3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-Cell Non-Hodgkin LymphomaHemic and Lymphatic Diseases, Neoplasms by Histologic Type, cancer, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmRecruitingPhase 12026-08-11NCT07603479
Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Diabetes Complications, Diabetic Foot, Disease Attributes, Foot Ulcer, Leg Ulcer, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Ulcer, Skin and Connective Tissue Diseases, arteriosclerosis disorder, arteriosclerosis obliterans, atherosclerosis, cardiovascular disorder, diabetes mellitus, diabetic neuropathy, diabetic peripheral angiopathy, endocrine system disorder, ischemic disease, peripheral arterial disease, peripheral vascular disease, skin disorder, thromboangiitis obliterans, vascular disorder, vasculitisEnrolling by invitationNot stated2025-07-11NCT07023965
Study of Safety and Efficacy of MY008211A in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor TherapyHemic and Lymphatic Diseases, Hemoglobinuria, Paroxysmal, anemia, bone marrow disorder, hematologic disorder, hemolytic anemia, myelodysplastic syndromeRecruitingPhase 32025-05-09NCT06932744